Sai Parenteral’s IPO Day 3: Check GMP, subscription status, and more – Should you apply on the final day?

Sai Parenteral’s IPO has received a weak response, being subscribed only 0.42 times by Day 2. The ₹409 crore IPO includes a fresh issue and an offer for sale. Analysts are divided on the company’s long-term potential versus current valuations.